医用乳酸菌对常用中草药的耐药性试验

目的 研究医用乳酸菌对几种常用中草药的耐药性,为医用乳酸菌与中草药的临床合并应用提供理论依据.方法 将中草药制成煎剂,通过琼脂扩散方法进行耐药性试验.结果 5种医用乳酸菌对黄连均表现出中度敏感,对黄芩表现微弱敏感.结论 5种医用乳酸菌对大部分中草药(包括有抗菌和抑菌作用的中草药)不敏感.     

食品中蜡样芽孢杆菌耐药性及其机制研究进展

蜡样芽孢杆菌是常见的食源性致病菌之一,其产生的毒素会引起食物中毒。蜡样芽孢杆菌主要引起2种类型的食物中毒,即呕吐和腹泻综合征,并可造成各种局部和全身感染。随着抗生素的广泛、大量使用,蜡样芽孢杆菌的耐药性不断增强,现已有报道出现多重耐药性。本文对蜡样芽孢杆菌的耐药现状及耐药性机制进行了综述,以期正确理解蜡样芽孢杆菌耐药性的特点及其规律,从而为防治蜡样芽孢杆菌耐药性的产生及合理用药提供理论依据。     

苏芸金芽孢杆菌与蜡状芽孢杆菌

苏芙金芽抱杆菌（ffecilliusthuringiensis简称B．t．）与蜡状芽抱杆菌（Bacilluscereus简称Bc,）这一对高度近缘细菌既有重要的经济意义又与人类的健康密切相关。B．l．在其芳抱形成期可产生杀虫晶体蛋白,已成为全球性应用最广泛的细菌杀虫剂［‘］二能产生多种有害毒素,诸如肠毒素、呕吐毒素、溶血素等,可引起人类非肠道感染及食物中毒,是人类的条件致病菌口。尽管B．t．杀虫剂有较好的完全性记录。但新近的文献表明,昆虫病原菌Bt．与人类的条件致病菌五C,的基因型及表现型非常相似,B．t．菌株也可产生对非靶标生物及人富有毒…     

动物用芽孢杆菌微生态制剂中蜡样芽孢杆菌的分离及安全性

【背景】芽孢杆菌是仅次于乳酸菌常用于微生态制剂中的菌种,然而部分芽孢杆菌微生态制剂规范不严,应用存在安全隐患。【目的】调查我国在售动物用芽孢杆菌微生态制剂中蜡样芽孢杆菌携带情况,揭示蜡样芽孢杆菌应用的潜在风险。【方法】对微生态制剂预处理,选择性筛选分离蜡样芽孢杆菌,通过全基因组测序测绘细菌毒素基因谱与耐药基因谱,细胞计数试剂盒-8法测定菌株对细胞的毒性,利用微量肉汤稀释法确定菌株耐药值。【结果】从50份微生态制剂产品中筛选分离得到23株蜡样芽孢杆菌群细菌,它们对氨苄西林、林可霉素和泰妙菌素3种抗生素均耐药,主要毒力基因nhe、hbl、cytK、ces的检出率分别为100%、30%、39%和4%,分离株均有溶血性且39%菌株产生热稳定毒素,不同菌株对非洲绿猴肾细胞呈现出不同程度的毒性。【结论】微生态制剂来源的蜡样芽孢杆菌毒性与耐药性严重,携带毒素基因与耐药基因广泛,多株菌株呈高细胞毒性且产生热稳定毒素。芽孢杆菌微生态制剂存在安全性问题,应加强对蜡样芽孢杆菌的质量安全监管力度,规范微生态制剂的市场秩序,杜绝安全隐患。     

芽孢杆菌对黄瓜根腐病的防治效果

枯草芽孢杆菌B29从黄瓜根际土壤分离,经实验室平板抑菌活性和温室盆栽防效测定,发现该菌对黄瓜根腐病有较强的抑菌作用,温室防效达79．7％-83．3％,且对瓜苗有一定的促生长作用。     

培养条件对凝结芽孢杆菌芽孢形成的影响

目的:提高凝结芽孢杆菌芽孢形成率及芽孢数量,为凝结芽孢杆菌芽孢制剂的产业化生产提供理论依据.方法:在摇瓶、15L自动发酵罐中考察了碳源、氮源、无机盐、微量元素Mn2+、pH、温度、接种量、溶氧水平对凝结芽孢杆菌液体培养形成芽孢的影响.结果:芽孢形成的最适培养基组成为:麸皮20g/L,酵母膏5g/L,豆粕粉10g/L,NaCl 5g/L,K2HPO4 3g/L,MnSO4.3g/L;最适培养条件为:初始pH7.0,接种后最适起始芽孢浓度为106CFU/mL,培养温度为40℃,180r/min摇瓶培养,250mL三角瓶中最适装液体积为15mL.在15L自动发酵罐中扩大培养,控制溶氧在30%以上,培养20h,芽孢数量可达5.8×109CFU/mL,芽孢率达96.7%.结论:试验获得的最佳培养条件可进一步应用于生产.     

重水对萎缩芽孢杆菌芽孢萌发的影响

本研究快报报道了重水对细菌芽孢的萌发及其可培养性的抑制作用. 在常温条件下,用L-丙氨酸触发细菌芽孢的萌发,并用Tb-DPA荧光法、相差显微镜观测法和光密度测定法监测萌发过程,用最终萌发水平、萌发半期、萌发速度3个参数来表征萌发过程. 除此之外,我们还用菌落形成单位的个数来评估萌发后芽孢的可培养性. 结果表明,重水对整个萌发过程有抑制作用,同时降低了萌发后芽孢的可培养性,但对最终萌发水平无影响. 我们推测这是因为重水增强了一些芽孢特异性信号蛋白的稳定性.     

我国部分地区土壤中的苏芸金芽孢杆菌和球形芽孢杆菌

从云南、贵州、四川和陕西4省的土壤中分离到大量苏芸金芽孢杆菌(Bacillus thuringie—nsis)和球形芽孢杆菌(Bacillus sphaeticus)菌株。血清型分析表明,苏芸金芽孢杆菌分离株分属于23个血清型中的13个血清型,另有近20％的自凝型菌株及部分与所有标准菌抗血清无反应的菌株。对该两种昆虫病原细菌的生态分布规律进行了分析。研究了全部苏芸金芽孢杆菌分离株对鳞翅目、鞘翅目及双翅目的6种昆虫的毒力特性、伴孢晶体与芽孢的形态,以及晶体蛋白质成分。观察和测定了球形芽孢杆菌分离株的形态和毒力,并分析了部分菌株的晶体蛋白质成分。得到22株高效苏芸金芽孢杆菌和2株高效球形芽孢杆菌。证明苏芸金芽孢杆菌是典型的土壤微生物类群,我国西南地区土壤中的苏芸金芽孢杆菌资源十分丰富。     

蜡样芽孢杆菌ATCC14579核黄素操纵子的克隆及在枯草芽孢杆菌中的表达

利用BLAST从B．cereus ATCC14579的基因组中找到一段与枯草芽孢杆茵核黄素操纵子具有较高相似性的4．6kb大小的基因组DNA片段,该片段中含有完整的核黄素操纵子。该操纵子结构基因的编码产物的氨基酸序列与枯草芽孢杆菌核黄素操纵子相应结构基因的编码产物的氨基酸序列具有99％的同源性。该片段被克隆到大肠杆茵一枯草芽孢杆茵穿梭载体pHP13M中。表达分析的结果表明B．cereus ATCC14579核黄素操纵子可在大肠杆茵和枯草芽孢杆菌中表达。利用PCR方法用来自枯草杆菌的sac B基因的启动子替换B．cereus ATCC14579核黄素操纵子原有的启动子使其更好表达。替换启动子后的核黄素操纵子在本文使用的发酵条件下有较好的表达,核黄素产量从39．5mg／L增加到61．7mg/L.     

临床常见病原性细菌对抗生素的耐药性分析

目的了解长春地区部分医院临床分离的致病菌对抗菌药物的耐药情况。方法收集吉林大学中日联谊医院和长春中医药大学附属医院临床分离的致病菌,采用K—B法进行抗生素敏感性试验,参照CLSI2009年版的标准判断结果。结果从这两家医院共分离细菌447株,其中革兰阴性菌353株,占78．9％,革兰阳性菌94株,占21．1％。肠杆菌科细菌对氨苄西林的耐药率在70％以上,对庆大霉素的耐药率超过了50％,但对亚胺培南保持较高的敏感性（耐药率〈5％）。金黄色葡萄球菌和表皮葡萄球菌对红霉素耐药率分别为65．2％和82．1％,对万古霉素的耐药率较低,分别为4．5％和3．6％。非发酵革兰阴性杆菌对头孢他啶的耐药率超过50％,铜绿假单胞菌对氨曲南的耐药率达到了62．9％,对他唑巴坦复合制剂、亚胺培南、美罗培南和阿米卡星较为敏感,而鲍曼不动杆菌对各类抗生素的耐药率都较高。结论细菌对抗生素的耐药性仍表现出增长趋势,加强细菌耐药性的检测,对于指导临床正确、合理使用抗生素,减少耐药菌的产生和传播具有重要意义。     

Effects of medicinal plant extracts from Chinese herbal medicines on the mutagenic activity of benzo[a]pyrene

The effects of medicinal plants on the mutagenicity of benzo[a]pyrene were studied with Salmonella typhimurium tester strains. The chosen medicinal plants are very frequently used as Chinese herbal medicines. Each medicinal plant was extracted with hot water, which is similar to the method used in Chinese medicinal treatment. Cinnamomi cortex, Rhei rhizoma, Scutellariae radix and Rehmanniae radix were found to decrease the mutagenic activity of benzo[a]pyrene. Atractylodis rhizoma also reduced the mutagenicity of benzo[a]pyrene, but this was not certain, because it showed a killing effect on the cell survival test. Bupleuri radix and Aurantii nobilis pericarpium had an enhancing effect, but then neither of these extracts is itself mutagenic. Each medicinal plant extract showed a different effect on the mutagenicity of benzo[a]pyrene. These effects were classified into 5 types: (I) decreasing effect, (II) killing effect, (III) enhancing effect, (IV) enhancing and decreasing effect and (V) inactive.     

中草药生物质炼制工程

目前我国中药产业面临资源紧张、药材利用率低、加工过程浪费严重等问题,究其原因主要是单一药效成分利用、加工转化技术落后所致。针对上述问题,从生物质炼制角度,综述了实现中草药资源高效利用的原料预处理、提取、转化及残渣后处理等4个关键单元操作中主要技术的研究进展,并指出中草药生物质炼制工程发展趋势与前景。     

鲍曼不动杆菌的耐药机制及其治疗药物

鲍曼不动杆菌已成为世界范围内导致院内感染的重要病原菌之一,环境适应能力及耐药能力强,因此给临床治疗带来了巨大的挑战。随着多种广谱抗生素尤其是碳青霉烯类的大量应用,使其耐药性不断增强,而新型药物的研发速度却远远无法满足临床需求,这种局面迫使对20世纪70年代弃用的粘菌素的再启用。此外,联合疗法似已显现了更高的杀菌活性,但具体的效果还有待进一步的临床试验证实。针对鲍曼不动杆菌的耐药机制以及有关的治疗药物进行综述,从而为防治相关感染以及研发新型药物提供理论基础。     

Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts

The aqueous extracts of 24 herbs traditionally used as curing ischemic heart disease in clinic in China were screened for their in vitro angiogenic activity, another twenty-four traditionally used as anti-tumor or anti-inflammatory remedies in China were screened for their in vitro anti-angiogenic activity. The activity of angiogenesis was determined by quantitation of vessels on chick embryo chorioallantoic membrane (CAM) model and cell proliferation of cultured bovine aortic endothelial cells (BAECs). Among the herbal extracts examined, the aqueous extracts of Epimedium sagittatum, Trichosanthes kirilowii and Dalbergia odorifera showed the strong angiogenetic activity both in CAM and BAECs models; and the aqueous extracts of Berberis paraspecta, Catharanthus roseus, Coptis chinensis, Taxus chinensis, Scutellaria baicalensis, Polygonum cuspidatum and Scrophularia ningpoensis elicited significant inhibition at a concentration of 1g dry herb /ml.     

中草药干预糖尿病肾病炎症的作用

随着糖尿病发病率逐年升高,糖尿病肾病成为导致慢性肾脏疾病和终末期肾脏疾病的主要原因。而目前控制血糖及抑制肾素-血管紧张素系统的药物治疗,并不能有效防止糖尿病肾病进展。近年来发现,慢性低水平炎症和免疫系统激活在糖尿病性肾病的发生及发展中起着至关重要的作用。明确糖尿病肾病进展中的炎症机制将有助于确定新的潜在靶点及研发抗炎治疗策略。越来越多的证据表明,中药治疗可以有效改善糖尿病性肾病的高血糖和蛋白尿,并能延缓其进展成为终末期肾病。糖尿病肾病动物实验和体外研究证实中药复方、中草药提取物和中药单体具有调节炎症介质的作用。本文旨在归纳总结文献中与糖尿病肾病肾损伤相关的炎症分子和途径,并探讨中草药靶向抗炎治疗糖尿病肾病的作用。     

Cochrane systematic reviews of Chinese herbal medicines: an overview

Objectives

Our study had two objectives: a) to systematically identify all existing systematic reviews of Chinese herbal medicines (CHM) published in Cochrane Library; b) to assess the methodological quality of included reviews.

Methodology/Principal Findings

We performed a systematic search of the Cochrane Database of Systematic Reviews (CDSR, Issue 5, 2010) to identify all reviews of CHM. A total of fifty-eight reviews were eligible for our study. Twenty-one of the included reviews had at least one Traditional Chinese Medicine (TCM) practitioner as its co-author. 7 reviews didn''t include any primary study, the remaining reviews (n = 51) included a median of 9 studies and 936 participants. 50% of reviews were last assessed as up-to-date prior to 2008. The questions addressed by 39 reviews were broad in scope, in which 9 reviews combined studies with different herbal medicines. For OQAQ, the mean of overall quality score (item 10) was 5.05 (95% CI; 4.58-5.52). All reviews assessed the methodological quality of primary studies, 16% of included primary studies used adequate sequence generation and 7% used adequate allocation concealment. Of the 51 nonempty reviews, 23 reviews were reported as being inconclusive, while 27 concluded that there might be benefit of CHM, which was limited by the poor quality or inadequate quantity of included studies. 58 reviews reported searching a median of seven electronic databases, while 10 reviews did not search any Chinese database.

Conclusions

Now CDSR has included large numbers of CHM reviews, our study identified some areas which could be improved, such as almost half of included reviews did not have the participation of TCM practitioners and were not up-to-date according to Cochrane criteria, some reviews pooled the results of different herbal medicines and ignored the searching of Chinese databases.